date:Aug 01, 2012
ustry was registered successfully in Brazil in late 2011 and subsequently in several Central American countries.
The tilapia industry is quickly adopting vaccination as a disease management tool because it fits with its strategy to produce healthy, profitable, high-quality fish for local and export markets, Mr Wendover added, noting that vaccinated fish often show significant performance improvements when compared to unvaccinated controls. MSD Animal Health is pursuing registrations for AQUAV